A new clinical trial, supported by the NIHR, will investigate whether a third dose of a COVID-19 vaccine will improve the immune response for people who have weakened immune systems.
Initial data from the NIHR-supported OCTAVE trial show that a significant proportion of patients with specific immunocompromised or immunosuppressed conditions, mount a low immune response after two doses of the COVID-19 vaccine.
Researchers leading an international study - jointly funded by an NIHR and Medical Research Council (MRC) partnership - have found a unique pair of gene variants that cause sudden onset high blood pressure in pregnant women.
The Department of Health and Social Care (DHSC) and the NIHR have announced a new £30 million Mental Health Research Initiative in order to help tackle the disparity between regional needs and mental health research activity.
The NIHR-supported RECOVERY-RS trial has demonstrated that treating hospitalised COVID-19 patients who have acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation.
Three international trial platforms have found that blood thinners improve survival and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients with COVID-19.
Professor Lucy Chappell has today taken up her new post as Chief Executive of the NIHR.
People experiencing long COVID will benefit from a comprehensive package of new NIHR-funded research to help improve the understanding of the condition, from diagnosis and treatment through to rehabilitation and recovery.
A large-scale, NIHR-supported observational study has found that one in two people hospitalised with COVID-19 developed at least one health complication as a result of the viral infection.
The latest NIHR Clinical Research Network (CRN) annual statistics show the extraordinary impact the organisation made in delivering vital clinical research during the 2020/21 pandemic.
The NIHR and Charities Consortium Hospice and Community Research are delighted to announce the winners of the 2021 NIHR and Charities Consortium Hospice and Community Research - Hospice Consortium Prizes.
Researchers leading an NIHR-funded study investigating cancer diagnosis and care in English prisons have highlighted the importance of former prisoners’ providing their ‘lived experience’ in shaping their work.
The NIHR has announced the launch of a new UK-wide professional accreditation scheme for Clinical Research Practitioners (CRPs) as part of efforts to double the number of this important workforce over the next few years.
Following publication of the ‘Saving and improving lives: the future of UK clinical research delivery’ vision in March, the UK government and devolved administrations today set out the first phase of activity.
Nearly a third of patients admitted to hospital with suspected COVID-19 during the first wave of the pandemic had a ‘Do Not Attempt Cardiopulmonary Resuscitation’ (DNACPR) decision recorded before, or on their day of admission to hospital, finds new NIHR-funded research.
A monoclonal antibody combination can help save lives of hospitalised patients with severe COVID-19 who were unable to generate an antibody response of their own before beginning treatment.
Many common dental procedures have a very low risk of increasing the aerosol spread of COVID-19, suggests new research funded by NIHR and UKRI.
The NIHR is delighted to announce that several prominent members of the NIHR family have received awards from Her Majesty Queen Elizabeth II as part of her birthday honours.
The NIHR-supported RECOVERY trial has found that the anti-inflammatory drug aspirin does not improve survival for patients who are hospitalised with COVID-19.
How emergency services are delivered at NHS hospitals – and what make-up of health professional staff provides the best patient experience - will be explored as part of an NIHR funded study involving healthcare experts from Kingston University and St George’s, University of London.
A new drug combination that is better at treating miscarriage is also more cost effective than current standard NHS treatment, finds a new NIHR-funded study.
A NIHR and UKRI funded study has found that people aged over 80 who received their second dose of the Pfizer–BioNTech mRNA vaccine after 12 weeks had significantly higher peak antibody levels than did those who received it after 3 weeks.
New research funded by the NIHR shows that algorithms can be as accurate as clinicians’ judgements for predicting how long terminally ill people with advanced cancer have left to live.
A single dose of either the Oxford-AstraZeneca or Pfizer-BioNTech vaccines leads to a substantial drop in the spread of COVID-19, new research supported by the NIHR has shown.
Treatment with the inhaled asthma drug budesonide reduces recovery time in patients with COVID-19 who are treated at home and in other community settings, new results from research funded and supported by the NIHR have shown.
